IVD quality control is used to observe and evaluate the accuracy of the analytical process utilized in diagnosing diseases. IVD Quality control products are specifically made from human serum, urine, whole blood, and plasma. They can be liquid or freeze dried (lyophilized). Clinical laboratories also use reference materials are also used for quality control purposes to deliver accurate and comparable test results."

VISIONARY LEADERS

Visionary leaders are the leading market players in terms of new developments such as product launches, innovative technologies, and the adoption of growth strategies. These players have a broad product offering that caters to most of the regions globally. Visionary leaders primarily focus on acquiring the leading market position through their strong financial capabilities and their well-established brand equity.

DYNAMIC DIFFERENTIATORS

Dynamic Differentiators are established players with very strong business strategies. However, they have a weaker product portfolio compared to the visionary leaders. They generally focus only on a specific type of technology related to the product.

INNOVATORS

Innovators in the competitive leadership mapping are vendors that have demonstrated substantial product innovations as compared to their competitors. The companies have focused on product portfolios. However, they do not have very strong growth strategies for their overall business, when compared with the visionary leaders.

EMERGING COMPANIES

Emerging companies have niche product and service offerings. Their business strategies are not as strong as that of the established vendors. The emerging vendors include the new entrants in the market, emerging in terms of product portfolio and geographic reach, and require time to gain significant traction in the market.

In Vitro Diagnostics/IVD Products

Comparing 22 vendors in In Vitro Diagnostics/IVD Products across 77 criteria.
All vendors(22)
The company offers a broad range of home blood glucose monitoring products for diabetes and point-of-care testing devices for in vitro diagnostics. Roche Diagnostics has established itself as a leader in the IVD market. The company’s new diagnostic tests and molecular testing systems are widely adopted by hospitals and healthcare providers, globally. Roche Diagnostics strongly invests in R&D activities to improve its existing product portfolio, as it has a strong pipeline of products for the growing IVD market
Read less Read more
Siemens operates through eight segments, namely, Power & Gas, Wind Power & Renewables, Energy Management, Building Technologies, Mobility, Digital Factory, Process Industries & Drives, and Healthcare. Siemens Healthineers, a leader in medical imaging and laboratory diagnostics, provides clinical diagnostics and therapeutic systems.
Read less Read more
Danaher operates through four strategic segments—Environmental & Applied Solutions, Dental, Life Sciences, and Diagnostics. The Life Sciences and Diagnostics segments offer analytical instruments, reagents, consumables, software, and services for various end users, including hospitals, physicians’ offices, reference laboratories, and other critical care settings for disease diagnosis. The company’s focus on product launches and development helps it enhance its market position. The global reach of the company also serves to reduce risks arising from dependence on a specific geography.
Read less Read more
The company’s biosciences business offers reagents, instruments, and consumables to conduct biological and medical research, discover new drugs and vaccines, and diagnose diseases. Its Specialty Diagnostics segment offers a wide range of diagnostic test kits, reagents, culture media, instruments, and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories.
Read less Read more
The company operates through five business segments, namely, Established Pharmaceuticals, Diagnostics, Nutritionals, Vascular Products, and Others. The company offers a wide range of products in various target therapeutic areas, including rheumatoid arthritis, HIV/AIDS, respiratory infections, cancer, diabetes, men's and women's health, and genetic conditions. The company also provides blood screening instruments and tests to various agencies. The company has a strong product portfolio, and its FDA- and CE-approved products have helped it to gain a sizable share of the IVD market. Abbott is presently focusing on developing next-generation instrument platforms, such as the PLEX-ID platform, and other advanced patient self-testing technologies.
Read less Read more